Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33973945)
Watch
English
The value of observational cohort studies for cancer drugs.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2899798
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22478817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
title
The value of observational cohort studies for cancer drugs
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2899798
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22478817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
author name string
David R Spigel
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2899798
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22478817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
publication date
1 January 2010
1 reference
stated in
Europe PubMed Central
PMC publication ID
2899798
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22478817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
published in
Biotechnology healthcare
1 reference
stated in
Europe PubMed Central
PMC publication ID
2899798
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22478817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
volume
7
1 reference
stated in
Europe PubMed Central
PMC publication ID
2899798
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22478817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
issue
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2899798
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22478817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
page(s)
18-24
1 reference
stated in
Europe PubMed Central
PMC publication ID
2899798
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22478817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
cites work
Phase 4 research grows despite lack of FDA oversight
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Adjuvant chemotherapy in older women with early-stage breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Follicular lymphoma in the United States: first report of the national LymphoCare study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
From randomized controlled trials to observational studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Limits of observational data in determining outcomes from cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Primer: challenges in randomized and observational studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Observational studies of drug safety--aprotinin and the absence of transparency
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
The risk associated with aprotinin in cardiac surgery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Treatment continuation in patients receiving biological agents or conventional DMARD therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Failing the public health--rofecoxib, Merck, and the FDA.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
A comparison of observational studies and randomized, controlled trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
An evaluation of the teratogenicity of certain antinauseant drugs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
5 July 2018
Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
29 October 2018
Dangerous deception--hiding the evidence of adverse drug effects.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
29 October 2018
Barriers to clinical trial participation by older women with breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
29 October 2018
Participation of patients 65 years of age or older in cancer clinical trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2899798
retrieved
29 October 2018
Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22478817
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Population-Based Studies of Adverse Drug Effects
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22478817
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22478817
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
In defense of pharmacoepidemiology--embracing the yin and yang of drug research
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22478817
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
PMC publication ID
2899798
1 reference
stated in
Europe PubMed Central
PMC publication ID
2899798
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22478817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
PubMed publication ID
22478817
1 reference
stated in
Europe PubMed Central
PMC publication ID
2899798
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22478817%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit